Login / Signup

Four consecutive minimal ovarian stimulation (TetraStim) is a feasible alternative to increase the number of oocytes and improve live birth rates in poor responders who do not accept oocyte donation.

Selmo GeberLuiza P GeberMarcello ValleMarcos Sampaio
Published in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2021)
To our knowledge this is the first study that demonstrates that TetraStim can be an effective alternative for patients with POR with an indication to perform IVF with donated oocytes, but do not agree to use. TetraStim is a feasible alternative to increase the number of oocytes and embryos and improve pregnancy rates with no dropouts and very low cycle cancelation rate. However, randomized controlled studies must be performed to compare TetraStim with other treatments.
Keyphrases
  • pregnancy outcomes
  • healthcare
  • double blind
  • open label
  • pregnant women
  • placebo controlled
  • clinical trial
  • case control